Found: 139
Select item for more details and to access through your institution.
Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 13, p. 2287, doi. 10.1002/cncr.35274
- By:
- Publication type:
- Article
Histologically Overt Stromal Response and the Risk of Progression after Radical Prostatectomy for Prostate Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1871, doi. 10.3390/cancers16101871
- By:
- Publication type:
- Article
Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1248, doi. 10.3390/cancers16071248
- By:
- Publication type:
- Article
Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21419, doi. 10.1002/cam4.6689
- By:
- Publication type:
- Article
MR-guided prostate SBRT in prostate cancer patients with low-volume metastatic disease.
- Published in:
- World Journal of Urology, 2023, v. 41, n. 12, p. 3889, doi. 10.1007/s00345-023-04675-7
- By:
- Publication type:
- Article
Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2340787, doi. 10.1001/jamanetworkopen.2023.40787
- By:
- Publication type:
- Article
Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 10, p. e2336390, doi. 10.1001/jamanetworkopen.2023.36390
- By:
- Publication type:
- Article
Acute toxicity comparison of magnetic resonance‐guided adaptive versus fiducial or computed tomography‐guided non‐adaptive prostate stereotactic body radiotherapy: A systematic review and meta‐analysis.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 19, p. 3044, doi. 10.1002/cncr.34836
- By:
- Publication type:
- Article
Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with Grade Group 5 prostate cancer.
- Published in:
- Histopathology, 2023, v. 82, n. 7, p. 1089, doi. 10.1111/his.14901
- By:
- Publication type:
- Article
Risk-adaptive paradigm for focal versus whole-gland salvage treatment for radio-recurrent prostate cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.998390
- By:
- Publication type:
- Article
Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy.
- Published in:
- Prostate, 2022, v. 82, n. 11, p. 1098, doi. 10.1002/pros.24362
- By:
- Publication type:
- Article
MRI-Based Radiotherapy Planning to Reduce Rectal Dose in Excess of Tolerance.
- Published in:
- Prostate Cancer (20903111), 2022, p. 1, doi. 10.1155/2022/7930744
- By:
- Publication type:
- Article
Common Dilemmas in Prostate Cancer Detection and Management.
- Published in:
- AUANews, 2021, p. 12
- By:
- Publication type:
- Article
Reply to Benefit-harm ratio of the diagnostic workup in patients with prostate cancer and a Gleason score of 9 to 10.
- Published in:
- 2021
- By:
- Publication type:
- letter
Prostate‐specific antigen nadir and testosterone level at prostate‐specific antigen failure following radiation and androgen suppression therapy for unfavorable‐risk prostate cancer and the risk of all‐cause and prostate cancer–specific mortality
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 15, p. 2623, doi. 10.1002/cncr.33543
- By:
- Publication type:
- Article
Prostate-specific antigen levels of ≤4 and >4 ng/mL and risk of prostate cancer-specific mortality in men with biopsy Gleason score 9 to 10 prostate cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association of Increased Prostate-Specific Antigen Levels After Treatment and Mortality in Men With Locally Advanced vs Localized Prostate Cancer: A Secondary Analysis of 2 Randomized Clinical Trials.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 5, p. e2111092, doi. 10.1001/jamanetworkopen.2021.11092
- By:
- Publication type:
- Article
Clinicopathological and molecular characteristics of prostate cancer diagnosed in young men aged up to 45 years.
- Published in:
- Histopathology, 2021, v. 78, n. 6, p. 857, doi. 10.1111/his.14315
- By:
- Publication type:
- Article
Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 4, p. e213304, doi. 10.1001/jamanetworkopen.2021.3304
- By:
- Publication type:
- Article
A Bayesian multi‐risks survival (MRS) model in the presence of double censorings.
- Published in:
- Biometrics, 2020, v. 76, n. 4, p. 1297, doi. 10.1111/biom.13228
- By:
- Publication type:
- Article
Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
- Published in:
- JAMA: Journal of the American Medical Association, 2020, v. 324, n. 17, p. 1747, doi. 10.1001/jama.2020.17020
- By:
- Publication type:
- Article
Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate Cancer.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 4, p. e202041, doi. 10.1001/jamanetworkopen.2020.2041
- By:
- Publication type:
- Article
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 5, p. e193759, doi. 10.1001/jamanetworkopen.2019.3759
- By:
- Publication type:
- Article
Reply to Partial gland therapy for prostate cancer.
- Published in:
- 2019
- By:
- Publication type:
- letter
Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.
- Published in:
- JAMA: Journal of the American Medical Association, 2019, v. 321, n. 7, p. 704, doi. 10.1001/jama.2018.19941
- By:
- Publication type:
- Article
Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Three-month posttreatment prostate-specific antigen level as a biomarker of treatment response in patients with intermediate-risk or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Androgen deprivation therapy use and risk of death in men treated with high-dose radiation for intermediate-risk prostate cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Screening for familial and hereditary prostate cancer.
- Published in:
- International Journal of Cancer, 2016, v. 138, n. 11, p. 2579, doi. 10.1002/ijc.29949
- By:
- Publication type:
- Article
Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer--Reply.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.
- Published in:
- BJU International, 2015, v. 116, n. 3, p. 358, doi. 10.1111/bju.12905
- By:
- Publication type:
- Article
Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 16, p. 2713, doi. 10.1002/cncr.29420
- By:
- Publication type:
- Article
ACR Appropriateness Criteria® Postradical Prostatectomy Irradiation in Prostate Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 12, p. 1125
- By:
- Publication type:
- Article
Progress and controversies: Radiation therapy for prostate cancer.
- Published in:
- CA: A Cancer Journal for Clinicians, 2014, v. 64, n. 6, p. 389, doi. 10.3322/caac.21250
- By:
- Publication type:
- Article
Using patient-reported outcomes to assess and improve prostate cancer brachytherapy.
- Published in:
- BJU International, 2014, v. 114, n. 4, p. 511, doi. 10.1111/bju.12464
- By:
- Publication type:
- Article
The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 12, p. 1787, doi. 10.1002/cncr.28609
- By:
- Publication type:
- Article
Impact of national guidelines on brachytherapy monotherapy practice patterns for prostate cancer.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 6, p. 824, doi. 10.1002/cncr.28492
- By:
- Publication type:
- Article
Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.
- Published in:
- BJU International, 2014, v. 113, n. 1, p. 43, doi. 10.1111/j.1464-410X.2012.11789.x
- By:
- Publication type:
- Article
Prior-Cancer Diagnosis in Men with Nonmetastatic Prostate Cancer and the Risk of Prostate-Cancer-Specific and All-Cause Mortality.
- Published in:
- ISRN Otolaryngology, 2014, p. 1, doi. 10.1155/2014/736163
- By:
- Publication type:
- Article
Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.
- Published in:
- Prostate Cancer (20903111), 2014, p. 1, doi. 10.1155/2014/230812
- By:
- Publication type:
- Article
Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial.
- Published in:
- Prostate Cancer (20903111), 2014, p. 1, doi. 10.1155/2014/478983
- By:
- Publication type:
- Article
Natural History of Untreated Prostate Specific Antigen Radio recurrent Prostate Cancer in Men with Favorable Prognostic Indicators.
- Published in:
- Prostate Cancer (20903111), 2014, p. 1, doi. 10.1155/2014/912943
- By:
- Publication type:
- Article